168 related articles for article (PubMed ID: 16382048)
1. A comprehensive strategy to combat colon cancer targeting the adenomatous polyposis coli tumor suppressor gene.
Gerner EW; Ignatenko NA; Lance P; Hurley LH
Ann N Y Acad Sci; 2005 Nov; 1059():97-105. PubMed ID: 16382048
[TBL] [Abstract][Full Text] [Related]
2. APC-dependent regulation of ornithine decarboxylase in human colon tumor cells.
Fultz KE; Gerner EW
Mol Carcinog; 2002 May; 34(1):10-8. PubMed ID: 12112318
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of intestinal polyposis with reduced angiogenesis in ApcMin/+ mice due to decreases in c-Myc expression.
Yekkala K; Baudino TA
Mol Cancer Res; 2007 Dec; 5(12):1296-303. PubMed ID: 18171987
[TBL] [Abstract][Full Text] [Related]
4. C-Myc is a critical mediator of the phenotypes of Apc loss in the intestine.
Wilkins JA; Sansom OJ
Cancer Res; 2008 Jul; 68(13):4963-6. PubMed ID: 18593890
[TBL] [Abstract][Full Text] [Related]
5. [Expression and significance of APC, beta-catenin, C-myc, and Cyclin D1 proteins in colorectal carcinoma].
Dai WB; Ren ZP; Chen WL; DU J; Shi Z; Tang DY
Ai Zheng; 2007 Sep; 26(9):963-6. PubMed ID: 17927853
[TBL] [Abstract][Full Text] [Related]
6. Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation.
Nilsson JA; Keller UB; Baudino TA; Yang C; Norton S; Old JA; Nilsson LM; Neale G; Kramer DL; Porter CW; Cleveland JL
Cancer Cell; 2005 May; 7(5):433-44. PubMed ID: 15894264
[TBL] [Abstract][Full Text] [Related]
7. Revival of 2-(difluoromethyl)ornithine (DFMO), an inhibitor of polyamine biosynthesis, as a cancer chemopreventive agent.
Raul F
Biochem Soc Trans; 2007 Apr; 35(Pt 2):353-5. PubMed ID: 17371277
[TBL] [Abstract][Full Text] [Related]
8. Clusterin-mediated apoptosis is regulated by adenomatous polyposis coli and is p21 dependent but p53 independent.
Chen T; Turner J; McCarthy S; Scaltriti M; Bettuzzi S; Yeatman TJ
Cancer Res; 2004 Oct; 64(20):7412-9. PubMed ID: 15492264
[TBL] [Abstract][Full Text] [Related]
9. Promoter hypermethylation leads to decreased APC mRNA expression in familial polyposis and sporadic colorectal tumours, but does not substitute for truncating mutations.
Segditsas S; Sieber OM; Rowan A; Setien F; Neale K; Phillips RK; Ward R; Esteller M; Tomlinson IP
Exp Mol Pathol; 2008 Dec; 85(3):201-6. PubMed ID: 18977219
[TBL] [Abstract][Full Text] [Related]
10. Can resistant starch and/or aspirin prevent the development of colonic neoplasia? The Concerted Action Polyp Prevention (CAPP) 1 Study.
Mathers JC; Mickleburgh I; Chapman PC; Bishop DT; Burn J;
Proc Nutr Soc; 2003 Feb; 62(1):51-7. PubMed ID: 12740057
[TBL] [Abstract][Full Text] [Related]
11. Response of colon cancer cell lines to the introduction of APC, a colon-specific tumor suppressor gene.
Groden J; Joslyn G; Samowitz W; Jones D; Bhattacharyya N; Spirio L; Thliveris A; Robertson M; Egan S; Meuth M
Cancer Res; 1995 Apr; 55(7):1531-9. PubMed ID: 7882361
[TBL] [Abstract][Full Text] [Related]
12. How the I1307K adenomatous polyposis coli gene variant contributes in the assessment of risk of colorectal cancer, but not stomach cancer, in a Turkish population.
Dundar M; Caglayan AO; Saatci C; Karaca H; Baskol M; Tahiri S; Ozkul Y
Cancer Genet Cytogenet; 2007 Sep; 177(2):95-7. PubMed ID: 17854661
[TBL] [Abstract][Full Text] [Related]
13. Development of difluoromethylornithine (DFMO) as a chemoprevention agent.
Meyskens FL; Gerner EW
Clin Cancer Res; 1999 May; 5(5):945-51. PubMed ID: 10353725
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2 inhibitors down-regulate osteopontin and Nr4A2-new therapeutic targets for colorectal cancers.
Zagani R; Hamzaoui N; Cacheux W; de Reyniès A; Terris B; Chaussade S; Romagnolo B; Perret C; Lamarque D
Gastroenterology; 2009 Oct; 137(4):1358-66.e1-3. PubMed ID: 19549529
[TBL] [Abstract][Full Text] [Related]
15. Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarboxylase gene.
Martinez ME; O'Brien TG; Fultz KE; Babbar N; Yerushalmi H; Qu N; Guo Y; Boorman D; Einspahr J; Alberts DS; Gerner EW
Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7859-64. PubMed ID: 12810952
[TBL] [Abstract][Full Text] [Related]
16. Ligand-dependent interaction between estrogen receptor alpha and adenomatous polyposis coli.
Kouzmenko AP; Takeyama K; Kawasaki Y; Akiyama T; Kato S
Genes Cells; 2008 Jul; 13(7):723-30. PubMed ID: 18498351
[TBL] [Abstract][Full Text] [Related]
17. Progression of colorectal cancers correlates with overexpression and loss of polarization of expression of the htid-1 tumor suppressor.
Kurzik-Dumke U; Hörner M; Czaja J; Nicotra MR; Simiantonaki N; Koslowski M; Natali PG
Int J Mol Med; 2008 Jan; 21(1):19-31. PubMed ID: 18097612
[TBL] [Abstract][Full Text] [Related]
18. [Promoter hypermethylation and loss of heterozygosity of the APC gene in patients with familial adenomatous polyposis].
Zhang YY; Chen SQ; Zhu M; Li JT; Ma GJ; Zhang XM; Zhou JN
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Aug; 25(4):378-81. PubMed ID: 18683131
[TBL] [Abstract][Full Text] [Related]
19. Novel detection and differential utilization of a c-myc transcriptional block in colon cancer chemoprevention.
Wilson AJ; Velcich A; Arango D; Kurland AR; Shenoy SM; Pezo RC; Levsky JM; Singer RH; Augenlicht LH
Cancer Res; 2002 Nov; 62(21):6006-10. PubMed ID: 12414619
[TBL] [Abstract][Full Text] [Related]
20. APC-dependent changes in expression of genes influencing polyamine metabolism, and consequences for gastrointestinal carcinogenesis, in the Min mouse.
Erdman SH; Ignatenko NA; Powell MB; Blohm-Mangone KA; Holubec H; Guillén-Rodriguez JM; Gerner EW
Carcinogenesis; 1999 Sep; 20(9):1709-13. PubMed ID: 10469614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
